Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CCL2 | P13500 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL3709891 | 0.96 | HTR6 (0.35) | HTR6SIGMAR1HTR2A | |
| SCHEMBL31357303 | 0.88 | HTR2A (0.40) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Fluoride Ion SCHEMBL1130379 | 0.86 | HTR2A (0.39) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Hydrochloric Acid SCHEMBL137960 | 0.86 | HTR2A (0.39) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Hydrochloric Acid SCHEMBL29424565 | 0.86 | HTR2A (0.39) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Bromide SCHEMBL615606 | 0.86 | HTR2A (0.43) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| SCHEMBL3838138 | 0.86 | HTR2A (0.39) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Hydrochloric Acid SCHEMBL820052 | 0.84 | HTR2A (0.38) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Hydrochloric Acid SCHEMBL30533388 | 0.84 | HTR2A (0.38) | HTR6SIGMAR1HTR2ABRD4CCL2 | |
| Ethylene SCHEMBL6910508 | 0.83 | BRD4 (0.35) | HTR6SIGMAR1HTR2ABRD4CCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125846-A2 | PROCESS FOR PREPARING DIALKYL OXIDE METALLOCENES OR DIARYL OXIDE METALLOCENES | Chemtura Organometallics GmbH (DE) | 2009-12-02 | — | — | EP | claimed |
| WO-2008104382-A2 | PROCESS FOR PREPARING DIALKYL OXIDE METALLOCENES OR DIARYL OXIDE METALLOCENES | CHEMTURA ORGANOMETALLICS GMBH (DE) | 2008-09-04 | — | — | WO | claimed |
| US-8383848-B2 | Transition metal compound and catalyst for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319578-A1 | TRANSITION METAL COMPOUND AND CATALYST FOR OLEFIN POLYMERIZATION | AP1M1, SOD1, YAP1 | HTR6 4382/4885SIGMAR1 3258/4885HTR2A 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.